The DOI matches its Crossref record.
Smallpox Vaccine: The Good, the Bad, and the Ugly
Open accessAbstract
Smallpox inarguably shaped the course of human history by killing countless millions in both the Old World and the New World.Dr. Edward Jenner's discovery of vaccination in the late 18th century, and the global eradication of smallpox in the 1970s, rank among the greatest achievements in human history.Amidst recent growing concerns about bioterrorism, smallpox vaccination has resurfaced from the history books to become a topic of major importance.Inoculation with vaccinia virus is highly effective for the prevention of smallpox infection, but it is associated with several known side effects that range from mild and self-limited to severe and life-threatening.As the United States moves forward with plans to vaccinate selected health care workers and the military, and perhaps offer the vaccination to all citizens in the future, it is important to fully understand and appreciate the history, risks, and benefits of smallpox vaccination. HISTORY OF SMALLPOX VACCINATION AND GLOBAL ERADICATIONSmallpox has been a scourge against humanity for at least the past 1500 years, and perhaps much longer than that.There is no mention of the disease in ancient Greek writings, but plagues of pustular disease in the Roman Empire bore a strong resemblance to smallpox.The literary record suggests that smallpox became established in the Mediterranean by the third century AD, and it was described in China around the same time.1 Smallpox subsequently changed the course of history and killed millions of people in both the New World and the Old World.Smallpox is caused by the variola virus, a DNA virus of the genus Orthopoxvirus.Humans are the only known reservoir for this virus.It is transmitted from person to person, and natural infection occurs by inhalation of respiratory droplets or contact with infected material on mucous membranes.Historical data suggest that smallpox is not highly transmissible, and high population densities are required to sustain transmission.Persons who have close, prolonged contact with an infected patient are at highest risk. 2 After a 10 to 14 day incubation period, the infected person develops severe symptoms with fever, malaise and headache.3 A maculopapular rash then develops with involvement of the face, mucous membranes, trunk and extremities.The lesions become pustular and deep over the subsequent 1 to 2 days, with scab formation by day 10.Patients are most infectious during the first week of the rash when viral shedding is greatest from ulcerated lesions in the oral mucosa.The overall mortality rate is about 30%, with most deaths occurring during the second week of illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Chung, Y. H., Beiss, V., Fiering, S. N., & Steinmetz, N. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c07197 · Cited by 346
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
Hettinga, J., & Carlisle, R. (2020) · Vaccines · doi:10.3390/vaccines8030534 · Cited by 72
Sato, R. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.09.097 · Cited by 26
Metadata
- Authors
- Belongia, E. A., & Naleway, A. L.
- Venue
- Clinical Medicine & Research
- Publisher
- Marshfield Clinic Research Institute
- Published
- 2003-04-01
- Volume
- 1
- Issue
- 2
- Pages
- 87-92
- ISSN
- 1539-4182 (ISSN-L)
- 1554-6179
- OpenAlex
- W2166157172
- Cited by
- 216
- References
- 0
- FWCI
- 0.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Smallpox Vaccine: The Good, the Bad, and the Ugly. https://app.cochat.ai/papers/10.3121/cmr.1.2.87
- The paper
- Belongia, E. A., & Naleway, A. L. (2003). Smallpox Vaccine: The Good, the Bad, and the Ugly. Clinical Medicine & Research. https://doi.org/10.3121/cmr.1.2.87
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.